Cdk2 acts upstream of mitochondrial permeability transition during paclitaxel-induced apoptosis

Abstract

Sequential activation of cyclin-dependent kinases (Cdks) controls mammalian cell cycle. Here we demonstrate that the upregulation of cyclin-dependent kinase 2 (Cdk2) activity coincides with the loss of mitochondrial membrane potential (MMP) in paclitaxel-induced apoptosis. Ectopic expression of the dominant negative Cdk2 (Cdk2-dn) and a specific Cdk2 inhibitor, p21^WAF1/CIP1, effectively suppresses the loss of MMP, the release of cytochrome c, and subsequent activation of caspase-3 in paclitaxel-treated cells. Whereas forced activation of Cdk2 by overexpression of cyclin A dramatically promotes these events. We further show that Cdk2 activation status does not interfere with a procedure that lies downstream of cytochrome c release induced by Bax protein. These findings suggest that Cdk2 kinase can regulate apoptosis at earlier stages than mitochondrial permeability transition and cytochrome c release.

Keywords

apoptosis / cyclin-dependent kinase 2 / cytochrome c release / mitochondrial membrane potential / paclitaxel

References

[1] André, N., Braguer, D., Brasseur, G., Gon?alves, A., Lemesle-Meunier, D., Guise, S., Jordan, M.A., and Briand, C. (2000). Paclitaxel induces release of cytochrome c from mitochondria isolated from human neuroblastoma cells’. Cancer Res 60, 5349–5353 .11034069
[2] Bruce, A., Edgar, T.L., and Terry, L.O. (2001). Endoreplication cell cycles: more for less. Cell 105, 297–306 .11348589
[3] Bastin-Coyette, L., Cardoen, S., Smal, C., de Viron, E., Arts, A., Amsailale, R., Van Den Neste, E., and Bontemps, F. (2011). Nucleoside analogs induce proteasomal down-regulation of p21 in chronic lymphocytic leukemia cell lines. Biochem Pharmacol 81, 586–593 .21168391
[4] Beere, H.M., Wolf, B.B., Cain, K., Mosser, D.D., Mahboubi, A., Kuwana, T., Tailor, P., Morimoto, R.I., Cohen, G.M., and Green, D.R. (2000). Heat-shock protein 70 inhibits apoptosis by preventing recruitment of procaspase-9 to the Apaf-1 apoptosome. Nat Cell Biol 2, 469–475 .10934466
[5] Breckenridge, D.G., and Xue, D. (2004). Regulation of mitochondrial membrane permeabilization by BCL-2 family proteins and caspases. Curr Opin Cell Biol 16, 647–652 .15530776
[6] Caroppi, P., Sinibaldi, F., Fiorucci, L., and Santucci, R. (2009). Apoptosis and human diseases: mitochondrion damage and lethal role of released cytochrome C as proapoptotic protein. Curr Med Chem 16, 4058–4065 .19754424
[7] Chipuk, J.E., and Green, D.R. (2008). How do BCL-2 proteins induce mitochondrial outer membrane permeabilization? Trends Cell Biol 18, 157–164 .18314333
[8] Chang, H., and Schimmer, A.D. (2007). Livin/melanoma inhibitor of apoptosis protein as a potential therapeutic target for the treatment of malignancy. Mol Cancer Ther 6, 24–30 .17237263
[9] Choi, J.S., Shin, S., Jin, Y.H., Yim, H., Koo, K.T., Chun, K.H., Oh, Y.T., Lee, W.H., and Lee, S.K. (2007). Cyclin-dependent protein kinase 2 activity is required for mitochondrial translocation of Bax and disruption of mitochondrial transmembrane potential during etoposide-induced apoptosis. Apoptosis 12, 1229–1241 .17252195
[10] Djeu, J.Y., and Wei, S. (2009). Clusterin and chemoresistance. Adv Cancer Res 105, 77–92 .19879424
[11] Donaldson, K.L., Goolsby, G.L., Kiener, P.A., and Wahl, A.F. (1994). Activation of p34cdc2 coincident with taxol-induced apoptosis. Cell Growth Differ 5, 1041–1050 .7848905
[12] Du, C., Fang, M., Li, Y., Li, L., and Wang, X. (2000). Smac, a mitochondrial protein that promotes cytochrome c-dependent caspase activation by eliminating IAP inhibition. Cell 102, 33–42 .10929711
[13] Gagandeep, S., Novikoff, P.M., Ott, M., and Gupta, S. (1999). Paclitaxel shows cytotoxic activity in human hepatocellular carcinoma cell lines. Cancer Lett 136, 109–118 .10211948
[14] Garrido, C., Galluzzi, L., Brunet, M., Puig, P.E., Didelot, C., and Kroemer, G. (2006). Mechanisms of cytochrome c release from mitochondria. Cell Death Differ 13, 1423–1433 .16676004
[15] Hiromura, K., Pippin, J.W., Blonski, M.J., Roberts, J.M., and Shankland, S.J. (2002). The subcellular localization of cyclin dependent kinase 2 determines the fate of mesangial cells: role in apoptosis and proliferation. Oncogene 21, 1750–1758 .11896606
[16] Hunt, J.T. (2009). Discovery of ixabepilone. Mol Cancer Ther 8, 275–281 .19174552
[17] Jin, Y.H., Yim, H., Park, J.H., and Lee, S.K. (2003). Cdk2 activity is associated with depolarization of mitochondrial membrane potential during apoptosis. Biochem Biophys Res Commun 305, 974–980 .12767926
[18] Jin, Y.H., Yoo, K.J., Lee, Y.H., and Lee, S.K. (2000). Caspase 3-mediated cleavage of p21^WAF1/CIP1 associated with the cyclin A-cyclin-dependent kinase 2 complex is a prerequisite for apoptosis in SK-HEP-1 cells. J Biol Chem 275, 30256–30263 .10884382
[19] Kaldis, P., and Aleem, E. (2005). Cell cycle control sibling rivalry: Cdc2 vs. Cdk2 Cell Cycle 4, 1491–1494 .16258277
[20] Levkau, B., Koyama, H., Raines, E.W., Clurman, B.E., Herren, B., Orth, K., Roberts, J.M., and Ross, R. (1998). Cleavage of p21^WAF1/CIP1 and p27^KIP1 mediates apoptosis in endothelial cells through activation of Cdk2: role of a caspase cascade. Mol Cell 1, 553–563 .9660939
[21] Li, K., Li, Y., Shelton, J.M., Richardson, J.A., Spencer, E., Chen, Z.J., Wang, X., and Williams, R.S. (2000). Cytochrome c deficiency causes embryonic lethality and attenuates stress-induced apoptosis. Cell 101, 389–399 .10830166
[22] Ling, Y.H., Tornos, C., and Perez-Soler, R. (1998). Phosphorylation of Bcl-2 is a marker of M phase events and not a determinant of apoptosis. J Biol Chem 273, 18984–18991 .9668078
[23] Liston, P., Fong, W.G., and Korneluk, R.G. (2003). The inhibitors of apoptosis: there is more to life than Bcl2. Oncogene 22, 8568–8580 .14634619
[24] Marupudi, N.I., Han, J.E., Li, K.W., Renard, V.M., Tyler, B.M., and Brem, H. (2007). Paclitaxel: a review of adverse toxicities and novel delivery strategies. Expert Opin Drug Saf 6, 609–621 .17877447
[25] Matthess, Y., Raab, M., Sanhaji, M., Lavrik, I.N., and Strebhardt, K. (2010). Cdk1/cyclin B1 controls Fas-mediated apoptosis by regulating caspase-8 activity. Mol Cell Biol 30, 5726–5740 .20937773
[26] Oltvai, Z.N., Milliman, C.L., and Korsmeyer, S.J. (1993). Bcl-2 heterodimerizes in vivo with a conserved homolog, Bax, that accelerates programmed cell death. Cell 74, 609–619 .8358790
[27] Pandey, P., Saleh, A., Nakazawa, A., Kumar, S., Srinivasula, S.M., Kumar, V., Weichselbaum, R., Nalin, C., Alnemri, E.S., Kufe, D., (2000). Negative regulation of cytochrome c-mediated oligomerization of Apaf-1 and activation of procaspase-9 by heat shock protein 90. EMBO J 19, 4310–4322 .10944114
[28] Placzek, W.J., Wei, J., Kitada, S., Zhai, D., Reed, J.C., and Pellecchia, M. (2010). A survey of the anti-apoptotic Bcl-2 subfamily expression in cancer types provides a platform to predict the efficacy of Bcl-2 antagonists in cancer therapy. Cell Death Dis 1, e40.
[29] Pradelli, L.A., Bénéteau, M., and Ricci, J.E. (2010). Mitochondrial control of caspase-dependent and -independent cell death. Cell Mol Life Sci 67, 1589–1597 .20151314
[30] Riedl, S.J., and Shi, Y. (2004). Molecular mechanisms of caspase regulation during apoptosis. Nat Rev Mol Cell Biol 5, 897–907 .15520809
[31] Rossé, T., Olivier, R., Monney, L., Rager, M., Conus, S., Fellay, I., Jansen, B., and Borner, C. (1998). Bcl-2 prolongs cell survival after Bax-induced release of cytochrome c. Nature 391, 496–499 .9461218
[32] Rowinsky, E.K., and Donehower, R.C. (1995). Paclitaxel (taxol). N Engl J Med 332, 1004–1014 . PMID:7885406Saleh, A., Srinivasula, S.M., Balkir, L., Robbins, P.D., and Alnemri, E.S. (2000). Negative regulation of the Apaf-1 apoptosome by Hsp70. Nat Cell Biol 2, 476–483 .10934467
[33] Salvesen, G.S., and Dixit, V.M. (1999). Caspase activation: the induced-proximity model. Proc Natl Acad Sci U S A 96, 10964–10967 .10500109
[34] Schiff, P.B., Fant, J., and Horwitz, S.B. (1979). Promotion of microtubule assembly in vitro by taxol. Nature 277, 665–667 .423966
[35] Shen, S.C., Huang, T.S., Jee, S.H., and Kuo, M.L. (1998). Taxol-induced p34cdc2 kinase activation and apoptosis inhibited by 12-O-tetradecanoylphorbol-13-acetate in human breast MCF-7 carcinoma cells. Cell Growth Differ 9, 23–29 .9438385
[36] Shi, Y. (2002). Mechanisms of caspase activation and inhibition during apoptosis. Mol Cell 9, 459–470 .11931755
[37] Stewart, Z.A., Mays, D., and Pietenpol, J.A. (1999). Defective G1-S cell cycle checkpoint function sensitizes cells to microtubule inhibitor-induced apoptosis. Cancer Res 59, 3831–3837 .10447002
[38] Willis, S.N., and Adams, J.M. (2005). Life in the balance: how BH3-only proteins induce apoptosis. Curr Opin Cell Biol 17, 617–625 .16243507
[39] Wu, H., Tschopp, J., and Lin, S.C. (2007). Smac mimetics and TNFalpha: a dangerous liaison? Cell 131, 655–658 .18022360
[40] Zhou, B.B., Li, H., Yuan, J., and Kirschner, M.W. (1998). Caspase-dependent activation of cyclin-dependent kinases during Fas-induced apoptosis in Jurkat cells. Proc Natl Acad Sci U S A 95, 6785–6790 .9618490